Back to URGN

MPM BioImpact LLC → URGN

MPM BioImpact LLC URGN Position History

UroGen Pharma Ltd. • Healthcare

Quarters held
4
Latest value
$37M
Q3 2026
Peak value
$37M
First seen
Q4 2025

Dollar value over time

Show data table
PeriodPosition value
Q4 2025$22M
Q1 2026$17M
Q2 2026$34.3M
Q3 2026$37M

Quarter-by-quarter history

Every disclosed snapshot of the position

QuarterValueShares% PortfolioChange
Q3 2026$37M909.7K——
Q2 2026$34.3M933.4K——
Q1 2026$17M943.8K——
Q4 2025$22M941.4K——

Other funds holding URGN

Other MPM BioImpact LLC positions

CGEM

Cullinan Therapeutics, Inc.

$177.2M
AKTS

Aktis Oncology, Inc.

$155.9M
CGEM

Cullinan Therapeutics, Inc.

$149.2M
LQDA

Liquidia Corporation

$110.5M
DBVTF

DBV Technologies S A

$108.9M
CGEM

Cullinan Therapeutics, Inc.

$108.7M
AKTS

Aktis Oncology, Inc.

$94.2M
RVMDW

Revolution Medicines, Inc.

$92.2M